Brammer Bio, Gene Therapy cGMP Manufacturing and QC Operations Facility

About this project

Project scope

Brammer has developed a new cGMP Manufacturing and QC Operations facility in an existing shell building. It comprises a self-contained, small-scale cGMP viral vector manufacturing operation embedded in a buildout of approximately 35,000 SF.

Features

The facility will include:

• cGMP manufacturing space
• Fill finish
• QC/Micro and PE scale-up lab space
• Loading dock and warehouse to support both cGMP and general operations
• Utilities to support operations

The first phase was designed to operate three upstream cell culture trains and three downstream purifications in parallel.